Earnings Outlook For Reshape Lifesciences
Portfolio Pulse from Benzinga Insights
Reshape Lifesciences (NASDAQ:RSLS) is set to release its latest quarterly earnings report on August 7, 2023. Analysts estimate an earnings per share (EPS) of $-1.79. The company's stock performance has been generally negative over the last 52-week period, with shares down 94.26%. Last quarter, the company beat EPS by $2.65, which was followed by a 4.88% drop in the share price.
August 04, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Reshape Lifesciences is expected to report an EPS of $-1.79. The company's shares have been on a downward trend, falling 94.26% over the past year. The last earnings beat led to a 4.88% drop in share price.
Given the negative trend in Reshape Lifesciences' stock price and the fact that the last earnings beat led to a drop in share price, it is likely that the upcoming earnings report could further negatively impact the stock price, especially if the company fails to meet the EPS estimate.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100